NCT06766123

Brief Summary

Retrospective study of adult patients with multivessel disease undergoing isolated CABG in three centers between January 1st, 2009, and December 31st, 2023. The primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE). Patients were grouped according to their ethnic origin, Arabs and Jews.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7,067

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2009

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
15 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 27, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 9, 2025

Completed
Last Updated

January 9, 2025

Status Verified

January 1, 2025

Enrollment Period

15 years

First QC Date

December 27, 2024

Last Update Submit

January 3, 2025

Conditions

CABGEthnic Group

Outcome Measures

Primary Outcomes (1)

  • MACCE

    through study completion, a median of 78 months

Secondary Outcomes (5)

  • Mortality

    through study completion, a median of 78 months

  • MI

    through study completion, a median of 78 months

  • CVA

    through study completion, a median of 78 months

  • repeat revascularization

    through study completion, a median of 78 months

  • utilization of multi-arterial grafting

    through study completion, a median of 78 months

Study Arms (2)

Arab ethnicity

All Arab patients undergoing isolated CABG

Procedure: CABG

Jew ethnicity

All Jew patients undergoing isolated CABG

Procedure: CABG

Interventions

CABGPROCEDURE

All patients underwent isolated CABG and retrospectively followed to asses ethnic disparities

Arab ethnicityJew ethnicity

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing isolated CABG at Carmel medical center, Beilinson medical center and Soroka medical center at Israel

You may qualify if:

  • isolated CABG

You may not qualify if:

  • members of different HMO

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of advanced cardiac surgery Department of cardiac surgery Carmel medical center

Study Record Dates

First Submitted

December 27, 2024

First Posted

January 9, 2025

Study Start

January 1, 2009

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

January 9, 2025

Record last verified: 2025-01